Werewolf Therapeutics, Inc. (NASDAQ:HOWL) combines selective tumor targeting, masking, and validated linker technology with ...

董事Evnin Luke报告在2026年1月8日至2026年1月12日期间出售了 Werewolf Therapeutics Inc (NASDAQ:HOWL) 的股票。这些交易总计53,533美元，执行价格在0.57美元至0.63美元之间。

Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to ...

Director Luke Evnin reported selling shares of Werewolf Therapeutics Inc (NASDAQ:HOWL) between December 2nd and December 4th, 2025. The sales, executed under a prearranged 10b5-1 trading plan, totaled ...

Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...